Aeon Biotherapeutics Corp.
FDA inspection history on file, 2025
- 1
- Form 483
Every document, by year
- Form 483
2025: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2025One Form 483.
Cited most
Across all Aeon Biotherapeutics observations on file
- 21 CFR 820.90(a)Nonconforming product2
- 21 CFR 820.100(a)Corrective and preventive action1
- 21 CFR 820.70(e)Production and process controls1
The complete Aeon Biotherapeutics file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-03-07 | 483 Form 483 | — | 4 | $99 |
Investigators on these documents
FEI number 3019027610 · most recent document Mar 7, 2025
About Aeon Biotherapeutics Corp.
How many FDA Form 483s has Aeon Biotherapeutics Corp. received?
FDA Intel has 1 Form 483 on file for Aeon Biotherapeutics Corp.; the most recent is dated Mar 7, 2025.
When was Aeon Biotherapeutics Corp. last inspected by FDA?
The most recent FDA inspection document on file for Aeon Biotherapeutics Corp. is a Form 483 dated Mar 7, 2025.
What did FDA cite at Aeon Biotherapeutics Corp.?
The regulations cited most in the observations on file for Aeon Biotherapeutics Corp. are 21 CFR 820.90(a) (Nonconforming product), 2 times; 21 CFR 820.100(a) (Corrective and preventive action), 1 time; 21 CFR 820.70(e) (Production and process controls), 1 time.